These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 10069377)

  • 21. HIV-1 regulatory protein tat induces RNA binding proteins in central nervous system cells that associate with the viral trans-acting-response regulatory motif.
    Kundu M; Ansari SA; Chepenik LG; Pomerantz RJ; Khalili K; Rappaport J; Amini S
    J Hum Virol; 1999; 2(2):72-80. PubMed ID: 10225209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitors of protein-RNA complexation that target the RNA: specific recognition of human immunodeficiency virus type 1 TAR RNA by small organic molecules.
    Mei HY; Cui M; Heldsinger A; Lemrow SM; Loo JA; Sannes-Lowery KA; Sharmeen L; Czarnik AW
    Biochemistry; 1998 Oct; 37(40):14204-12. PubMed ID: 9760258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-HIV-1 activity of anti-TAR polyamide nucleic acid conjugated with various membrane transducing peptides.
    Tripathi S; Chaubey B; Ganguly S; Harris D; Casale RA; Pandey VN
    Nucleic Acids Res; 2005; 33(13):4345-56. PubMed ID: 16077030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Jembrana disease virus Tat can regulate human immunodeficiency virus (HIV) long terminal repeat-directed gene expression and can substitute for HIV Tat in viral replication.
    Chen H; He J; Fong S; Wilcox G; Wood C
    J Virol; 2000 Mar; 74(6):2703-13. PubMed ID: 10684286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthetic access to spacer-linked 3,6-diamino-2,3,6-trideoxy-alpha-D-glucopyranosides--potential aminoglycoside mimics for the inhibition of the HIV-1 TAR-RNA/Tat-peptide complex.
    Jöge T; Jesberger M; Bröker P; Kirschning A
    Carbohydr Res; 2007 Sep; 342(12-13):1704-14. PubMed ID: 17562328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The RNA element encoded by the trans-activation-responsive region of human immunodeficiency virus type 1 is functional when displaced downstream of the start of transcription.
    Churcher MJ; Lowe AD; Gait MJ; Karn J
    Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2408-12. PubMed ID: 7892280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-function relationship of novel X4 HIV-1 entry inhibitors - L- and D-arginine peptide-aminoglycoside conjugates.
    Hegde R; Borkow G; Berchanski A; Lapidot A
    FEBS J; 2007 Dec; 274(24):6523-36. PubMed ID: 18028446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of diverse microbial metabolites as potent inhibitors of HIV-1 Tat transactivation.
    Jayasuriya H; Zink DL; Polishook JD; Bills GF; Dombrowski AW; Genilloud O; Pelaez FF; Herranz L; Quamina D; Lingham RB; Danzeizen R; Graham PL; Tomassini JE; Singh SB
    Chem Biodivers; 2005 Jan; 2(1):112-22. PubMed ID: 17191924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequence-specific interaction of Tat protein and Tat peptides with the transactivation-responsive sequence element of human immunodeficiency virus type 1 in vitro.
    Cordingley MG; LaFemina RL; Callahan PL; Condra JH; Sardana VV; Graham DJ; Nguyen TM; LeGrow K; Gotlib L; Schlabach AJ
    Proc Natl Acad Sci U S A; 1990 Nov; 87(22):8985-9. PubMed ID: 2247474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TAR-RNA recognition by a novel cyclic aminoglycoside analogue.
    Raghunathan D; Sánchez-Pedregal VM; Junker J; Schwiegk C; Kalesse M; Kirschning A; Carlomagno T
    Nucleic Acids Res; 2006; 34(12):3599-608. PubMed ID: 16855296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-TAR polyamide nucleotide analog conjugated with a membrane-permeating peptide inhibits human immunodeficiency virus type 1 production.
    Kaushik N; Basu A; Palumbo P; Myers RL; Pandey VN
    J Virol; 2002 Apr; 76(8):3881-91. PubMed ID: 11907228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
    Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
    Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short communication: a single step assay for rapid evaluation of inhibitors targeting HIV type 1 Tat-mediated long terminal repeat transactivation.
    Chande AG; Baba M; Mukhopadhyaya R
    AIDS Res Hum Retroviruses; 2012 Aug; 28(8):902-6. PubMed ID: 21878060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electrostatic interactions modulate the RNA-binding and transactivation specificities of the human immunodeficiency virus and simian immunodeficiency virus Tat proteins.
    Tao J; Frankel AD
    Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1571-5. PubMed ID: 8434019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and synthesis of a novel peptidomimetic inhibitor of HIV-1 Tat-TAR interactions: squaryldiamide as a new potential bioisostere of unsubstituted guanidine.
    Lee CW; Cao H; Ichiyama K; Rana TM
    Bioorg Med Chem Lett; 2005 Oct; 15(19):4243-6. PubMed ID: 16054360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of RNA cleavage catalyzed by sequence specific polyamide nucleic acid-neamine conjugate.
    Chaubey B; Tripathi S; Désiré J; Baussanne I; Décout JL; Pandey VN
    Oligonucleotides; 2007; 17(3):302-13. PubMed ID: 17854270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of Small Molecules with a Noncanonical Binding Mode to HIV-1 Trans Activation Response (TAR) RNA.
    Abulwerdi FA; Shortridge MD; Sztuba-Solinska J; Wilson R; Le Grice SF; Varani G; Schneekloth JS
    J Med Chem; 2016 Dec; 59(24):11148-11160. PubMed ID: 28002966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Cyclic Mimic of HIV Tat Differentiates Similar TAR RNAs on the Basis of Distinct Dynamic Behaviors.
    Lu J; Nguyen L; Zhao L; Xia T; Qi X
    Biochemistry; 2015 Jun; 54(23):3687-93. PubMed ID: 26016940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nuclear Factor 90(NF90) targeted to TAR RNA inhibits transcriptional activation of HIV-1.
    Agbottah ET; Traviss C; McArdle J; Karki S; St Laurent GC; Kumar A
    Retrovirology; 2007 Jun; 4():41. PubMed ID: 17565699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-guided discovery of a novel aminoglycoside conjugate targeting HIV-1 RNA viral genome.
    Ennifar E; Aslam MW; Strasser P; Hoffmann G; Dumas P; van Delft FL
    ACS Chem Biol; 2013 Nov; 8(11):2509-17. PubMed ID: 24015986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.